Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genevest (now operating as Reference Capital SA) is a pioneering Swiss venture capital firm based in Geneva, specializing in the life sciences, biotechnology, and medical technology sectors. Founded in 1983, it was the first venture capital organization in Switzerland and has played a foundational role in developing the Swiss biotech ecosystem. The firm provides strategic investment and support to early-stage and growth-stage companies, with a portfolio that has historically included major industry players such as Actelion, Addex Therapeutics, and SOPHiA GENETICS. Genevest focuses on backing innovative therapeutic platforms and technologies that address significant unmet medical needs globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Genevest.